Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $668.89 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $142.77 | 2 | $0 (2023) |
| Novo Nordisk Inc | $119.45 | 4 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $115.80 | 2 | $0 (2021) |
| AbbVie Inc. | $68.26 | 2 | $0 (2023) |
| PFIZER INC. | $44.85 | 3 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $36.94 | 2 | $0 (2020) |
| Edwards Lifesciences Corporation | $30.74 | 1 | $0 (2021) |
| ITI, Inc. | $24.38 | 1 | $0 (2022) |
| Amgen Inc. | $23.64 | 1 | $0 (2021) |
| Fresenius USA Marketing, Inc. | $16.65 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $152.50 | 2 | E.R. Squibb & Sons, L.L.C. ($126.00) |
| 2022 | $232.65 | 9 | Novo Nordisk Inc ($119.45) |
| 2021 | $233.21 | 8 | AstraZeneca Pharmaceuticals LP ($115.80) |
| 2020 | $50.53 | 3 | Alexion Pharmaceuticals, Inc. ($36.94) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/08/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $126.00 | General |
| Category: Cardiovascular | ||||||
| 01/24/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/19/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.67 | General |
| 10/12/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $92.99 | General |
| Category: Obesity | ||||||
| 08/15/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: PSYCHIATRY | ||||||
| 08/10/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.47 | General |
| 08/10/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $0.32 | General |
| 05/10/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/13/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $41.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 01/19/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/05/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/11/2021 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 07/15/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/20/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Cardiology | ||||||
| 05/13/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/06/2021 | Edwards Lifesciences Corporation | HemoSphere (Device) | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: Hemodynamic Monitoring | ||||||
| 03/30/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $105.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/10/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.77 | General |
| Category: Cardiovascular | ||||||
| 10/22/2020 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/14/2020 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.13 | General |
| 08/25/2020 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.81 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 43 | 74 | $24,997 | $4,735 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 59 | $18,172 | $3,439 | 18.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 15 | $6,825 | $1,295 | 19.0% |
About Dr. Albert Cheng, DO
Dr. Albert Cheng, DO is a Internal Medicine healthcare provider based in Robbinsdale, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2020. The National Provider Identifier (NPI) number assigned to this provider is 1265056469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Cheng, DO has received a total of $668.89 in payments from pharmaceutical and medical device companies, with $152.50 received in 2023. These payments were reported across 22 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($668.89).
As a Medicare-enrolled provider, Cheng has provided services to 43 Medicare beneficiaries, totaling 74 services with total Medicare billing of $4,735. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Robbinsdale, MN
- Active Since 06/03/2020
- Last Updated 08/10/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1265056469
Products in Payments
- ELIQUIS (Drug) $187.62
- FARXIGA (Drug) $105.50
- Saxenda (Drug) $92.99
- UBRELVY (Drug) $41.76
- HemoSphere (Device) $30.74
- DALVANCE (Drug) $26.50
- CAPLYTA (Drug) $24.38
- Repatha (Biological) $23.64
- Velphoro (Drug) $16.65
- XERAVA (Drug) $16.09
- ZENPEP (Drug) $15.73
- DIFICID (Drug) $13.59
- BRILINTA (Drug) $10.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Robbinsdale
Vy Jocson
Internal Medicine — Payments: $47,752
Dr. Sean Stoy, Md, MD
Internal Medicine — Payments: $37,376
Tarek Hamieh, Md, MD
Internal Medicine — Payments: $5,422
Chike Obi
Internal Medicine — Payments: $2,301
Ben Bache-Wiig, M.d, M.D
Internal Medicine — Payments: $1,299
Abdisamad Ibrahim, Md, MD
Internal Medicine — Payments: $1,217